Jiangxi Dadi Pharmaceutical Ltd Liability Company
APIs (levofloxacin hydrochloride, levofloxacin lactate, ciprofloxacin hydrochloride, simvastatin, moxifloxacin, ofloxacin, norfloxacin), API intermediates (moxifloxacin side chain, gaticyclyl ester, gaticarboxylic acid, levofluorocarboxylic acid, cyclopropylcarboxylic acid, oxyfluorocarboxylic acid, norfluorocarboxylic acid, trimethyl orthoformate, triethyl orthoformate, trimethyl orthoacetate, norfloxacin chelate), import and export rights, mixtures (A line, B line), oral solutions (A line, B line), syrups (A line, B line), wine (including Chinese medicine processing and extraction) (operated with valid license); production and operation of chemical raw materials and products (except dangerous goods) (projects that must be approved according to law can only be carried out after approval by relevant departments)
Business TypeManufacturer
LocationChina Jiangxi Pingxiang
Year Established2000-12-01
TotalEmployees184
Total Annual Revenue-
Main products1,2-Diallyl phthalate, SAP, tris(hydroxymethyl)aminomethane, blue copper peptide, lactic acid, gatifloxacin, norfloxacin, solvent orange 2, ciprofloxacin, cyclopentanetetracarboxylic anhydride, methylcyclohexenetetracarboxylic anhydride, methylnadic anhydride, peroxyacetic acid, formic acid, formic acid, hydrochloric acid, hydrochloric acid, levofloxacin hydrochloride, ciprofloxacin hydrochloride, silicone oil, biphenyl dianhydride, norfloxacin, simvastatin, ester
Main Market-